Search Results 41-50 of 17092 for Dutasteride
... dutasteride), must be discontinued ≥ 2 weeks before the first dose of study drug. Exclusion Criteria: Use of any of these therapies ≤ 12 months prior to ...
Bicalutamide is used together with a luteinizing hormone releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate ...
Dutasteride; Fosamprenavir; Mometasone; Oxybutynin; Paricalcitol; Pioglitazone; Prednisone; Tolbutamide. Other Interactions. Certain medicines should not be ...
(i.e., CRPC participants). 2. Other hormonal therapy; e.g.: - Use of estrogens, 5-? reductase inhibitors (finasteride, dutasteride), other steroidogenesis ...
At least 4 weeks must have elapsed from the use of 5-α reductase inhibitors (e.g., dutasteride, finasteride), estrogens, and cyproterone to randomization; ...
Mayo Clinic scientists are working to improve the diagnosis and treatment of multiple endocrine neoplasia, type 2, also called MEN 2. Researchers study the ...
Amprenavir; Cerivastatin; Clonazepam; Dalfopristin; Delavirdine; Desipramine; Didanosine; Dutasteride; Efavirenz; Eltrombopag; Fosamprenavir; Gemfibrozil ...
Deutetrabenazine is used to treat movement disorders, including tardive dyskinesia and chorea caused by Huntington's disease. Deutetrabenazine works in the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.